| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |